{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T12:27:43Z","timestamp":1784982463549,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["R01DK101500"],"award-info":[{"award-number":["R01DK101500"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1053\/j.ajkd.2016.11.018","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T17:49:23Z","timestamp":1486748963000},"page":"191-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Diabetes Control and the Risks of ESRD and Mortality in\u00a0Patients\u00a0With CKD"],"prefix":"10.1053","volume":"70","author":[{"given":"Sankar D.","family":"Navaneethan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse D.","family":"Schold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey E.","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Arrigain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang C.","family":"Winkelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Joseph V.","family":"Nally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.ajkd.2016.11.018_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"9844","key":"10.1053\/j.ajkd.2016.11.018_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"issue":"24","key":"10.1053\/j.ajkd.2016.11.018_bib3","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"305","author":"de Boer","year":"2011","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2016.11.018_bib4","unstructured":"USRDS. Incidence, prevalence, patient characteristics, and treatment modalities. 2016(08\/04). 2016."},{"issue":"2","key":"10.1053\/j.ajkd.2016.11.018_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2016.11.018_bib6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2016.11.018_bib7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"24","key":"10.1053\/j.ajkd.2016.11.018_bib8","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMe0803831","article-title":"Glycemic targets and cardiovascular disease","volume":"358","author":"Cefalu","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2016.11.018_bib9","first-page":"S39","article-title":"Standards of medical care in diabetes-2016","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"issue":"21","key":"10.1053\/j.ajkd.2016.11.018_bib10","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1001\/archinternmed.2011.537","article-title":"Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study","volume":"171","author":"Shurraw","year":"2011","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2016.11.018_bib11","doi-asserted-by":"crossref","first-page":"e0130828","DOI":"10.1371\/journal.pone.0130828","article-title":"Extreme levels of HbA1c increase incident ESRD risk in Chinese patients with type 2 diabetes: competing risk analysis in national cohort of Taiwan Diabetes\u00a0Study","volume":"10","author":"Liao","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1053\/j.ajkd.2016.11.018_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2014.296","article-title":"Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes","volume":"87","author":"Papademetriou","year":"2015","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2016.11.018_bib13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2337\/dc15-2322","article-title":"Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON","volume":"39","author":"Wong","year":"2016","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1053\/j.ajkd.2016.11.018_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinternmed.2011.2230","article-title":"Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes","volume":"172","author":"Coca","year":"2012","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1053\/j.ajkd.2016.11.018_bib15","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2215\/CJN.00800209","article-title":"Frequency of hypoglycemia and its significance in chronic kidney disease","volume":"4","author":"Moen","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2016.11.018_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2215\/CJN.04230510","article-title":"Development and validation of an electronic health record-based chronic kidney disease registry","volume":"6","author":"Navaneethan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2016.11.018_bib17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2016.11.018_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.kint.2015.12.002","article-title":"Body mass index and causes of death in chronic kidney disease","volume":"89","author":"Navaneethan","year":"2016","journal-title":"Kidney Int"},{"issue":"446","key":"10.1053\/j.ajkd.2016.11.018_bib19","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A\u00a0proportional hazards models for the\u00a0subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1053\/j.ajkd.2016.11.018_bib20","unstructured":"KDIGO. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. 2016(08\/04). 2013. http:\/\/www.kdigo.org\/clinical_practice_guidelines\/pdf\/CKD\/KDIGO_2012_CKD_GL.pdf. Accessed January 30, 2017."},{"key":"10.1053\/j.ajkd.2016.11.018_bib21","unstructured":"Centers for Disease Control and Prevention. Leading causes of death-2014. 2016(08\/04). 2016. https:\/\/www.cdc.gov\/nchs\/fastats\/leading-causes-of-death.htm. Accessed January 30, 2017."},{"issue":"9982","key":"10.1053\/j.ajkd.2016.11.018_bib22","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)62459-4","article-title":"Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis","volume":"385","author":"Palmer","year":"2015","journal-title":"Lancet"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616307107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638616307107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:58:53Z","timestamp":1759460333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638616307107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0272638616307107"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.11.018","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes Control and the Risks of ESRD and Mortality in\u00a0Patients\u00a0With CKD","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2016.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}